Nurse Practitioner · New Orleans, LA
NPI
1083782734
Since 2006
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2000 Canal St
New Orleans, LA, 70112
Phone (504) 702-3000
Groups this clinician bills Medicare through
Medicare paid, 2023
$1,413
45 services
Medicare patients, 2023
17
Average age 63
Drug cost, 2024
$661K
118 prescriptions
Company payments, 2025
$2,771
From 12 companies
Procedures and visits billed to Original Medicare, 2023
In 2023, the most common Medicare service billed by Lolita Camp was code 91200 (standard x-ray), 13 times for 11 patients. In total Lolita Camp billed 45 services in 8 codes, and Medicare paid $1,413.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 91200 Standard X-ray | Facility | 13 | 11 | $6.01 | $78.1 |
By year: 2022 $1,623 for 46 services; 2023 $1,413 for 45 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lolita Camp prescribed most often to Medicare patients was Sofosbuvir-Velpatasvir (Sofosbuvir/Velpatasvir), with 21 prescriptions and refills. In total Lolita Camp wrote 118 Medicare prescriptions that cost $661K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sofosbuvir-Velpatasvir Sofosbuvir/Velpatasvir | 21 | 22 | Under 11 | $184K |
| Tenofovir Disoproxil Fumarate Generic | 21 | 23 | Under 11 | $649 |
| Epclusa Sofosbuvir/Velpatasvir | 17 | 19 | Under 11 | $464K |
Brand drugs: 47 claims; generic drugs: 71 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lolita Camp $2,771 ($2,771 in general payments such as food, travel and fees) from 12 companies. The largest payer was Gilead Sciences, Inc. with $974.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 11 | $974 |
| Madrigal Pharmaceuticals MDGL | 2 | $270 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $243 |
| ViiV Healthcare Company GSK | 2 | $227 |
| Abbott Laboratories ABT | 1 | $163 |
| Medtronic, Inc. MDT | 1 | $151 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $140 |
| Alexion Pharmaceuticals, Inc. AZN | 1 | $135 |
| Corcept Therapeutics CORT | 1 | $125 |
| Genzyme Corporation SNY | 1 | $125 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.